An Open-label Long-term Safety Study of Buntanetap in Participants With AD
Study sponsor: Annovis Bio Inc. · ANVS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2030-02-21Estimated
Enrollment · participants400Estimated
Source updated2026-11-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.